EMA Shortens Regulatory Path For Antibacterials Against Multidrug Resistant Pathogens
This article was originally published in The Pink Sheet Daily
Executive Summary
Following new guidance from the European Medicines Agency, marketing approvals for antibacterials against multi-resistant bugs could be granted in Europe on expanded Phase II clinical trial data, a path that multinational Roche is keen to explore.